dc.contributor.author | Gregersen, Ida | |
dc.contributor.author | Skjelland, Mona | |
dc.contributor.author | Holm, Sverre | |
dc.contributor.author | Holven, Kirsten Bjørklund | |
dc.contributor.author | Sørensen, Kirsten | |
dc.contributor.author | Russell, David | |
dc.contributor.author | Askevold, Erik Tandberg | |
dc.contributor.author | Dahl, Christen Peder | |
dc.contributor.author | Ørn, Stein | |
dc.contributor.author | Gullestad, Lars | |
dc.contributor.author | Mollnes, Tom Eirik | |
dc.contributor.author | Ueland, Thor | |
dc.contributor.author | Aukrust, Pål | |
dc.contributor.author | Halvorsen, Bente | |
dc.date.accessioned | 2014-03-20T14:46:29Z | |
dc.date.available | 2014-03-20T14:46:29Z | |
dc.date.issued | 2013 | |
dc.description.abstract | Objective: Atherosclerosis is a chronic inflammatory disorder that involves a range of inflammatory mediators. Although
interleukin (IL)-9 has been related to inflammation, there are at present no data on its role in atherosclerosis. Here we have
examined IL-9 and IL-9 receptor (IL-9R) systemically and locally in patients with coronary and carotid atherosclerosis.
Methods: Plasma IL-9 was quantified by enzyme immunoassay and multiplex technology. IL-9 and IL-9R mRNA were
quantified by real-time RT-PCR, and their localization within the lesion was assessed by immunohistochemistry.
Results: The main findings were: (i) Patients with carotid atherosclerosis had significantly raised IL-9 plasma levels compared
with healthy controls (n = 28), with no differences between asymptomatic (n = 56) and symptomatic (n = 88) patients. (ii) On
admission, patients with acute ST-elevation myocardial infarction (STEMI) (n = 42) had markedly raised IL-9 plasma levels
which gradually declined during the first week post-MI. (iii) T cells and monocytes from patients with unstable angina
(n = 17) had increased mRNA levels of IL-9 as compared with controls (n = 11). (iv) Carotid plaques (n = 68) showed increased
mRNA levels of IL-9 and IL-9R compared to non-atherosclerotic vessels (n = 10). Co-localization to T cells (IL-9 and IL-9R) and
macrophages (IL-9) were shown by immunohistochemistry. (v) IL-9 increased IL-17 release in peripheral blood mononuclear
cells from patients with unstable angina (n = 5) and healthy controls (n = 5) with a particularly enhancing effect in cells from
the patient group.
Conclusion: Our findings show increased IL-9 levels in different atherosclerotic disorders both systemically and within the
lesion, suggesting a role for the IL-9/IL-9R axis in the atherosclerotic process, potentially involving IL-17 mediated
mechanisms. However, the functional consequences of these findings should be further investigated. | en |
dc.identifier.citation | PLoS ONE (2013). vol. 8(8): e72769. | en |
dc.identifier.cristinID | FRIDAID 1063016 | |
dc.identifier.doi | http://dx.doi.org/10.1371/journal.pone.0072769 | |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | https://hdl.handle.net/10037/6004 | |
dc.identifier.urn | URN:NBN:no-uit_munin_5697 | |
dc.language.iso | eng | en |
dc.publisher | Public Library of Science (PLoS) | en |
dc.rights.accessRights | openAccess | |
dc.subject | VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Cardiology: 771 | en |
dc.subject | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771 | en |
dc.title | Increased Systemic and Local Interleukin 9 Levels in Patients with Carotid and Coronary Atherosclerosis | en |
dc.type | Journal article | en |
dc.type | Tidsskriftartikkel | en |
dc.type | Peer reviewed | en |